|
Name |
11-Mercaptoundecanoic acid
|
Molecular Formula | C11H22O2S | |
IUPAC Name* |
11-sulfanylundecanoic acid
|
|
SMILES |
C(CCCCCS)CCCCC(=O)O
|
|
InChI |
InChI=1S/C11H22O2S/c12-11(13)9-7-5-3-1-2-4-6-8-10-14/h14H,1-10H2,(H,12,13)
|
|
InChIKey |
GWOLZNVIRIHJHB-UHFFFAOYSA-N
|
|
Synonyms |
11-Mercaptoundecanoic acid; 71310-21-9; 11-Sulfanylundecanoic acid; Undecanoic acid, 11-mercapto-; 11-mercaptoundecanoicacid; 10-Caroboxy-1-decanethiol; 11-Sulfanylundecanoic acid #; SCHEMBL111144; DTXSID00337585; 11-Mercaptoundecanoic acid, 95%; 11-Mercaptoundecanoic acid, 98%; ZINC2164257; MFCD00022096; STL323763; AKOS015893928; CS-W014785; DB08171; GS-6888; DB-008035; FT-0698883; F11363; A866466; Q27097399
|
|
CAS | 71310-21-9 | |
PubChem CID | 543502 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 218.36 | ALogp: | 4.0 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 38.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 14 | QED Weighted: | 0.425 |
Caco-2 Permeability: | -5.187 | MDCK Permeability: | 0.00002600 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.808 |
30% Bioavailability (F30%): | 0.95 |
Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 99.39% |
Volume Distribution (VD): | 0.435 | Fu: | 2.76% |
CYP1A2-inhibitor: | 0.066 | CYP1A2-substrate: | 0.2 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.216 |
CYP2C9-inhibitor: | 0.077 | CYP2C9-substrate: | 0.972 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.148 |
CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.029 |
Clearance (CL): | 6.439 | Half-life (T1/2): | 0.805 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.228 |
Drug-inuced Liver Injury (DILI): | 0.053 | AMES Toxicity: | 0.074 |
Rat Oral Acute Toxicity: | 0.102 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.722 | Carcinogencity: | 0.316 |
Eye Corrosion: | 0.937 | Eye Irritation: | 0.984 |
Respiratory Toxicity: | 0.869 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000102 | 0.773 | D0Z5BC | 0.596 | ||||
ENC000270 | 0.705 | D0E4WR | 0.510 | ||||
ENC000378 | 0.680 | D0O1PH | 0.479 | ||||
ENC000551 | 0.654 | D0XN8C | 0.441 | ||||
ENC000916 | 0.654 | D07ILQ | 0.435 | ||||
ENC000466 | 0.642 | D0FD0H | 0.432 | ||||
ENC000088 | 0.636 | D05ATI | 0.410 | ||||
ENC000050 | 0.607 | D05QNO | 0.381 | ||||
ENC001913 | 0.596 | D0Y8DP | 0.379 | ||||
ENC000593 | 0.596 | D0O1TC | 0.378 |